Castle Biosciences, Inc. (CSTL)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 12:58PM EST. Market open.
| Previous close | 25.71 |
| Open | 25.57 |
| Bid | 24.97 x 800 |
| Ask | 25.09 x 800 |
| Day's range | 24.19 - 25.57 |
| 52-week range | 15.58 - 48.40 |
| Volume | |
| Avg. volume | 204,769 |
| Market cap | 657.736M |
| Beta (5Y monthly) | 1.07 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Increasing losses over year doesn't faze Castle Biosciences (NASDAQ:CSTL) investors as stock jumps 11% this past week
Castle Biosciences, Inc. ( NASDAQ:CSTL ) shareholders should be happy to see the share price up 11% in the last week...
- Zacks
Castle Biosciences, Inc. (CSTL) Reports Q3 Loss, Tops Revenue Estimates
Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of -10% and 7.73%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Vertex Pharmaceuticals' (VRTX) New AAT Corrector Enters Clinic
The FDA clears Vertex's (VRTX) Investigational New Drug application for VX-634, a small molecule AAT corrector, thereby allowing the company to initiate a first-in-human clinical study in healthy volunteers.
© 2022 Yahoo. All rights reserved.
